Search

everythinglearnresearchcommunity

for

Search:↓

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Not having enough cystatin M/E protein causes less hair growth and dry skin.

New compounds show promise as nonsteroidal treatments for hair loss.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

The protein EZH2 blocks microRNA-22, increasing STK40 protein, which helps hair follicle stem cells change and grow hair.

QLT0267 stops hair follicle cell growth and movement.

Statins do not help improve alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

The hair growth serum Trichosera® was effective in increasing hair regrowth and density and reducing hair fall without significant side effects.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Trypsin slows hair growth and affects color by causing cell death in hair follicles.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Topical minoxidil can help improve hair in trichonodosis.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Akkermansia muciniphila may help prevent testosterone-related hair loss.

Dexamethasone speeds up hair loss in mice, while cyclosporin A slows it down.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Increased Stat3 activity reduces hair follicle stem cells and boosts other stem/progenitor cells.